Advertisement

Topics

Scientia Vascular Company Profile

21:03 EDT 21st July 2018 | BioPortfolio


News Articles [256 Associated News Articles listed on BioPortfolio]

New Scientia Vascular Product Facilitates Stroke Treatment

Scientia Vascular, an early stage medical device company with patented and proprietary vascular access technology, recently received FDA clearance for a new product called the Ari...

From Vascular Medicine: Focus on vascular imaging and diagnostics

(SAGE) Vascular disease is a leading cause of morbidity and death worldwide. In order to combat the disease, specialists must have skills with imaging techniques. With this in mind, Vascular Medicine,...

Vascular Endothelial Growth Factor remains unchanged in cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia

Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players i...

Access Vascular brings in $1.9mm

In what appears to be its second financing, Access Vascular Inc. raised $1.9mm from seven undisclosed investors. The company could raise another $2.1mm in the round. Earlier this year, Access Vascular...

Intact Vascular gets $20mm in Series C

Intact Vascular Inc. (devices for minimally invasive peripheral vascular procedures) raised $20mm in its Series C financing to New Enterprise Associates, HIG BioVentures, and Quaker Partners. The fund...

Corindus’ CorPath GRX cleared for both PCI, peripheral vascular intervention

Already approved for robot-assisted PCI, Corindus

Intact Vascular completes enrollment in Tack Optimized Balloon Angioplasty III trial

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has

Medical News Today: These antibiotics may endanger vascular health

Researchers in Sweden and Denmark find new evidence that suggests that a type of antibiotic can increase the risk of a potentially fatal vascular disease.

PubMed Articles [1179 Associated PubMed Articles listed on BioPortfolio]

Vascular Anomalies (Part II): Interventional Therapy of Peripheral Vascular Malformations.

 The International Society for the Study of Vascular Anomalies (ISSVA) categorizes vascular anomalies into vascular tumors and vascular malformations. Vascular malformations are further divided into...

The role of adventitia in hypoxic vascular remodeling.

As an important site for the production, storage and release of key regulators for vascular function, the vascular adventitia is thought to be a damage sensing tissue in the vascular wall under certai...

Recent trends in Publications of US and European Directors in Vascular Surgery.

We hypothesized that there may be significant differences between academic productivity of the vascular training programs in the United States (US) and Europe. In an effort to explore theory, we revie...

Early Treatment at a Referral Center Improves Outcomes for Patients with Acute Vascular Disease.

Patients with acute vascular disease frequently need specialized management that may require transfer to a vascular referral center. While transfer may be medically necessary, it can delay definitive ...

Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies.

 Vascular anomalies are a diagnostic and therapeutic challenge. They require dedicated interdisciplinary management. Optimal patient care relies on integral medical evaluation and a classification s...

Clinical Trials [1808 Associated Clinical Trials listed on BioPortfolio]

Patient Comfort With Vascular Closure

The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...

Clinical Study of POSS-PCU Vascular Grafts for Vascular Access

This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be e...

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Reduced antiplatelet activity (low response (LR)/high on-treatment platelet reactivity (HPR)) of aspirin (ALR) or clopidogrel (CLR) is associated with an increased risk of thromboembolic e...

A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population

SafeBreak Vascular is a medical device indicated for fluid flow control during the administration of IV fluids/medication to the patient's vascular system and to aid in the prevention of u...

Study to Evaluate Safety & Effectiveness of Vascular Sealant System

To evaluate a new vascular sealant compared to control for the control of suture line bleeding after vascular reconstructive surgery.

Companies [321 Associated Companies listed on BioPortfolio]

Scientia Advisors, LLC

Scientia Advisors, based in Boston and San Francisco, is a growth strategy firm for the healthcare industry. Scientia works closely with senior management to develop corpor...

Scientia Vascular

ex scientia Ltd.

ex scientia is a privately owned company developing new medicines for a wide range of human diseases where improved efficacy is required. ex scientia is the first company t...

Scientia Advisors

Scientia Advisors, located in Boston and San Francisco, is a management consulting firm specializing in growth strategies for major and emerging companies in healthcare, li...

LeMaitre Vascular

LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices t...

More Information about "Scientia Vascular" on BioPortfolio

We have published hundreds of Scientia Vascular news stories on BioPortfolio along with dozens of Scientia Vascular Clinical Trials and PubMed Articles about Scientia Vascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Scientia Vascular Companies in our database. You can also find out about relevant Scientia Vascular Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record